RecallDepth
Class II Terminated

GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.

Company
Sciegen Pharmaceuticals Inc
Recall Initiated
October 29, 2018
Posted
November 28, 2018
Recall Number
D-0271-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
18,760 HDPE bottles
Firm Location
Hauppauge, NY, United States

Reason for Recall

CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.

Distribution

Nationwide

Lot / Code Info

60429-641-90 Irbesartan 150mg Tablets, 90 Count Bottle B161003 Sep-19 B161004 Sep-19 B161006 Sep-19 B161007 Sep-19 B161008 Nov-19 B161009 Nov-19 B161010 Nov-19 C161001 Feb-20 C161003 May-20 60429-641-30 Irbesartan 150mg Tablets, 30 Count Bottle GS019526 Nov-19 GS020252 Nov-19 GS020958 Nov-19

More recalls by Sciegen Pharmaceuticals Inc

View all recalls by this company →

Other recent Class II Drug recalls